Remdesivir: Ask the Experts
ACPE Activity Number: None
Release Date: August 5, 2020
Expirations Date: August 5, 2023
Activity Type: Knowledge-based
CE Credits: None
Activity Fee: Members/Non-Member – Free
Overview
The latest remdesivir information will be shared with participants, including a review of information about the remdesivir distribution process, utilization protocols implemented in some hospitals, and clinical considerations for remdesivir use. This one-hour session will consist of brief presentations by panelists followed by a facilitated 30-minute question-and-answer session with the panelists.
Join us as experts share their experiences managing the distribution and use of remdesivir and share their knowledge about remdesivir treatment in hospitalized COVID-19 patients.
Learning Objectives
After completing this activity, the learner should be able to…
- Recall the current process used to allocate and distribute remdesivir to hospitals
- Describe strategies to ensure equitable availability of remdesivir to patients
- Explain the role of remdesivir in treating hospitalized COVID-19 patients
Speakers
Erin Fox, PharmD, BCPS, FASHP
Senior Pharmacy Director, Drug Information & Support Services
University of Utah Health
Salt Lake City, Utah
Mark Sullivan, PharmD, MBA, BCPS, FASHP
Associate Chief Pharmacy Officer
Vanderbilt University Hospitals & Clinics
Nashville, TN
Curtis Collins PharmD, MS, BCPS (AQ-ID), FASHP
Infectious Diseases Clinical Specialist
St. Joseph Mercy Health
Ypsilanti, Michigan